C Boesecke
Overview
Explore the profile of C Boesecke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
301
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyerhoff P, Manekeller S, Saleh N, Boesecke C, Schlabe S, Wasmuth J, et al.
Epidemiol Infect
. 2021 Mar;
149:e119.
PMID: 33734061
Rabies post-exposure prophylaxis (R-PEP) including wound treatment, vaccination and application of rabies immunoglobulin (RIG) is essential in preventing rabies mortality. Today, Germany is officially declared free from terrestrial rabies and...
2.
Dold L, Zimmer L, Schwarze-Zander C, Boesecke C, Mohr R, Wasmuth J, et al.
J Mol Med (Berl)
. 2020 Dec;
99(1):147-158.
PMID: 33278000
HLA-B*57 affects the course of HIV infection. Under antiretroviral therapy, its effects cannot be explained by outstandingly efficient T cell responses alone but may also involve cells of innate immunity....
3.
Paul G, Wesselmann J, Adzic D, Malin J, Suarez I, Priesner V, et al.
HIV Med
. 2020 Oct;
22(3):165-171.
PMID: 33128333
Objectives: Non-treponemal serological tests are used to monitor treatment response during syphilis infection. Syphilis- and HIV-coinfected patients may experience incomplete resolution in non-treponemal titres, which is referred to as the...
4.
Dohla M, Boesecke C, Schulte B, Diegmann C, Sib E, Richter E, et al.
Public Health
. 2020 Apr;
182:170-172.
PMID: 32334183
Objective: With the current SARS-CoV2 outbreak, countless tests need to be performed on potential symptomatic individuals, contacts and travellers. The gold standard is a quantitative polymerase chain reaction (qPCR)-based system...
5.
Schwarze-Zander C, Piduhn H, Boesecke C, Schlabe S, Stoffel-Wagner B, Wasmuth J, et al.
HIV Med
. 2020 Feb;
21(6):378-385.
PMID: 32065713
Objectives: Development of novel antiretrovirals aims at reducing long-term toxicities. Tenofovir disoproxil fumarate (TDF) has been associated with potential nephrotoxicity. The aim of our study was to assess the impact...
6.
Dold L, Schwarze-Zander C, Boesecke C, Mohr R, Langhans B, Wasmuth J, et al.
Sci Rep
. 2019 Aug;
9(1):12502.
PMID: 31467319
HIV/HCV infection is supposed to substantially reduce survival as compared to HIV mono-infection. Here, we compared longtime-survival and causes of death in a cohort of HIV- and HIV/HCV-co-infected patients on...
7.
Spinner C, Lang G, Boesecke C, Jessen H, Schewe K
HIV Med
. 2019 May;
20(6):368-376.
PMID: 31140708
Objectives: HIV Pre-Exposure prophylaxis (PrEP) is a strategy to reduce HIV transmission in people at risk. Aim of this first German-Austrian PrEP guideline is to provide professional guidance on: when...
8.
Malin J, Boesecke C, Schwarze-Zander C, Wasmuth J, Schlabe S, Trebicka J, et al.
HIV Med
. 2019 Jan;
20(3):230-236.
PMID: 30687989
Objectives: The aim of the study was to assess the regression of liver stiffness after successful direct-acting antiviral (DAA) treatment in patients with hepatitis C virus (HCV) monoinfection and HCV/-HIV...
9.
von Felden J, Vermehren J, Ingiliz P, Mauss S, Lutz T, Simon K, et al.
Aliment Pharmacol Ther
. 2018 Mar;
47(9):1288-1295.
PMID: 29536554
Background: Twelve weeks of the pangenotypic direct-acting antiviral (DAA) combination sofosbuvir/velpatasvir (SOF/VEL) was highly efficient in patients with hepatitis C virus (HCV) genotype 3 (GT3) infection in the ASTRAL-3 approval...
10.
Ryom L, Boesecke C, Bracchi M, Ambrosioni J, Pozniak A, Arribas J, et al.
HIV Med
. 2018 Mar;
19(5):309-315.
PMID: 29493093
Background: The European AIDS Clinical Society (EACS) Guidelines have since 2005 provided multidisciplinary recommendations for the care of HIV-positive persons in geographically diverse areas. Guideline Highlights: Major revisions have been...